{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T10:58:39Z","timestamp":1783076319489,"version":"3.54.6"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajconline.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.amjcard.2018.09.029","type":"journal-article","created":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T21:02:37Z","timestamp":1537995757000},"page":"44-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparison of In-Hospital Bleeding and Cardiovascular Events with High-Dose Bolus Tirofiban and Shortened Infusion to Short-Duration Eptifibatide as Adjunctive Therapy for Percutaneous Coronary Intervention"],"prefix":"10.1016","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5210-4552","authenticated-orcid":false,"given":"Gabrielle L.","family":"Anderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Osborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Nei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm R.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory W.","family":"Barsness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin C.","family":"Mara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narith N.","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2018.09.029_bib0001","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","article-title":"2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes","volume":"64","author":"Amsterdam","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2018.09.029_bib0002","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1016\/j.jacc.2012.11.019","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction","volume":"61","author":"O'Gara","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2018.09.029_bib0003","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/HPC.0000000000000079","article-title":"Comparison of 1-year major adverse cardiac events in patients undergoing primary percutaneous coronary intervention receiving intracoronary bolus only versus intracoronary bolus plus infusion of glycoprotein IIb\/IIIa inhibitors","volume":"15","author":"Kassaian","year":"2016","journal-title":"Crit Pathw Cardiol"},{"key":"10.1016\/j.amjcard.2018.09.029_bib0004","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ijcard.2011.08.082","article-title":"Beneficial effects of intracoronary tirofiban bolus administration following upstream intravenous treatment in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: The ICT-AMI study","volume":"165","author":"Zhu","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2018.09.029_bib0005","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jacc.2004.06.050","article-title":"Achieved platelet aggregation inhibition after different antiplatelet regimens during percutaneous coronary intervention for ST-segment elevation myocardial infarction","volume":"44","author":"Ernst","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2018.09.029_bib0006","first-page":"53","article-title":"High-dose tirofiban administered as bolus-only during percutaneous coronary intervention","volume":"20","author":"Marmur","year":"2008","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.amjcard.2018.09.029_bib0007","series-title":"Prescribing Information","year":"2014"},{"key":"10.1016\/j.amjcard.2018.09.029_bib0008","series-title":"Prescribing Information","year":"2016"},{"key":"10.1016\/j.amjcard.2018.09.029_bib0009","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/S0140-6736(96)10172-0","article-title":"Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2018.09.029_bib0010","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199808133390704","article-title":"Inhibition of platelet glycoprotein IIb\/IIIa with eptifibatide in patients with acute coronary syndromes","volume":"339","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2018.09.029_bib0011","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1001\/jama.285.19.2468","article-title":"Platelet glycoprotein IIb\/IIIa integrin blockade with eptifibatide in coronary stent intervention: the ESPRIT trial","volume":"285","author":"O'Shea","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2018.09.029_bib0012","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1056\/NEJM199805213382103","article-title":"A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina","volume":"338","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2018.09.029_bib0013","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1056\/NEJM199805213382102","article-title":"Inhibition of the platelet glycoprotein IIb\/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction","volume":"338","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2018.09.029_bib0014","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1161\/01.CIR.96.5.1445","article-title":"Effects of platelet glycoprotein IIb\/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty","volume":"96","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2018.09.029_bib0015","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jacc.2004.03.042","article-title":"The additive value of tirofiban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty: the ADVANCE trial","volume":"44","author":"Valgimigli","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2018.09.029_bib0016","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/ccd.22876","volume":"77","author":"Moliterno","year":"2011","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2018.09.029_bib0017","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jcin.2012.01.006","volume":"5","author":"Valgimigli","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2018.09.029_bib0018","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.amjcard.2014.12.031","article-title":"Effect of a shortened-duration eptifibatide infusion (75 mg) as adjunctive therapy for percutaneous coronary intervention on inhospital cardiovascular outcomes and bleeding","volume":"115","author":"Nei","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2018.09.029_bib0019","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1016\/j.jacc.2013.07.101","article-title":"Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding","volume":"62","author":"Tantry","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2018.09.029_bib0020","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2459\/JCM.0b013e32833cdd04","article-title":"Long-term efficacy of high-dose tirofiban versus double-bolus eptifibatide in patients undergoing percutaneous coronary intervention","volume":"12","author":"Schiariti","year":"2011","journal-title":"J Cardiovasc Med"},{"key":"10.1016\/j.amjcard.2018.09.029_bib0021","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/1755-5922.12203","article-title":"A randomized trial assessing the impact of three different glycoprotein IIb\/IIIa antagonists on glycoprotein IIb\/IIIa platelet receptor inhibition and clinical endpoints in patients with acute coronary syndromes","volume":"34","author":"Holmes","year":"2016","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.amjcard.2018.09.029_bib0022","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1001\/jama.299.15.joc80026","article-title":"Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial","volume":"299","author":"Valgimigli","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2018.09.029_bib0023","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0140-6736(08)61235-0","article-title":"Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial","volume":"372","author":"Van't Hof","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2018.09.029_bib0024","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jcin.2011.08.018","article-title":"Transradial versus transfemoral intervention for acute myocardial infarction: a propensity score-adjusted and -matched analysis from the REAL (REgistro regionale AngioLastiche dell'Emilia-Romagna) multicenter registry","volume":"5","author":"Valgimigli","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2018.09.029_bib0025","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1161\/CIRCINTERVENTIONS.108.846741","article-title":"Bleeding in patients undergoing percutaneous coronary intervention: the development of a clinical risk algorithm from the National Cardiovascular Data Registry","volume":"2","author":"Mehta","year":"2009","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2018.09.029_bib0026","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005562","article-title":"Ticagrelor and eptifibatide bolus versus ticagrelor and eptifibatide bolus with 2-hour infusion in high-risk acute coronary syndromes patients undergoing early percutaneous coronary intervention","volume":"6","author":"Marian","year":"2017","journal-title":"J Am Heart Assoc"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914918318502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914918318502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T12:55:27Z","timestamp":1544187327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914918318502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0002914918318502"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2018.09.029","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of In-Hospital Bleeding and Cardiovascular Events with High-Dose Bolus Tirofiban and Shortened Infusion to Short-Duration Eptifibatide as Adjunctive Therapy for Percutaneous Coronary Intervention","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2018.09.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}